Atea Pharmaceuticals, Inc. Earnings Per Share Diluted

Quick Answer

Atea Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $1.94 (loss) per share for the year ending 2025.

  • Atea Pharmaceuticals, Inc. showed an increase of +3.0% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Atea Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Atea Pharmaceuticals, Inc.'s Earnings Per Share Diluted has declined by 39.6%.
  • Historical annual values: Fiscal year 2025: $1.94 (loss) per share | Fiscal year 2024: $2.00 (loss) per share | Fiscal year 2023: $1.63 (loss) per share | Fiscal year 2022: $1.39 (loss) per share | Fiscal year 2021: $1.37 per share | Fiscal year 2020: $0.51 (loss) per share | Fiscal year 2019: $1.39 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: